🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Roger Song

Stock Analyst at Jefferies

(2.12)
# 3,222
Out of 5,189 analysts
275
Total ratings
38.4%
Success rate
0.3%
Average return

Stocks Rated by Roger Song

Prelude Therapeutics
Nov 19, 2026
Maintained: Buy
Price Target: $9 → $8
Current: $3.23
Upside: +147.68%
Inovio Pharmaceuticals
Nov 6, 2026
Rated: Buy
Price Target: $3 → $8
Current: $1.76
Upside: +354.55%
AbCellera Biologics
Oct 30, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $9.69
Upside: +116.72%
Artiva Biotherapeutics
Oct 28, 2026
Downgraded: Hold
Price Target: $4
Current: $3.78
Upside: +5.82%
Replimune Group
Oct 28, 2026
Rated: Buy
Price Target: $24 → $29
Current: $19.07
Upside: +52.07%
Vaxcyte
Oct 5, 2026
Reiterated: Buy
Price Target: $146
Current: $55.39
Upside: +163.59%
Nektar Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $121 → $150
Current: $30.20
Upside: +396.69%
United Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $704
Current: $554.73
Upside: +26.91%
Viking Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $101
Current: $24.77
Upside: +307.75%
Structure Therapeutics
Sep 8, 2026
Reiterated: Buy
Price Target: $125
Current: $16.13
Upside: +674.95%
Reiterated: Buy
Price Target: $182
Current: $119.52
Upside: +52.28%
Reiterated: Buy
Price Target: $48
Current: $11.02
Upside: +335.57%
Reiterated: Buy
Price Target: $52
Current: $28.40
Upside: +83.10%
Reiterated: Buy
Price Target: $45 → $133
Current: $95.81
Upside: +38.82%
Reiterated: Buy
Price Target: $62 → $21
Current: $4.28
Upside: +390.65%
Reiterated: Buy
Price Target: $83
Current: $63.34
Upside: +31.04%
Rated: Buy
Price Target: $371 → $474
Current: $308.89
Upside: +53.45%
Reiterated: Buy
Price Target: $45
Current: $12.85
Upside: +250.19%
Initiated Coverage: Buy
Price Target: $11
Current: $2.81
Upside: +291.46%
Initiated Coverage: Buy
Price Target: $4
Current: $0.919
Upside: +335.26%
Reiterated: Buy
Price Target: $58 → $71
Current: $93.90
Upside: -24.38%
Reiterated: Buy
Price Target: $10
Current: $0.6277
Upside: +1,493.12%
Rated: Buy
Price Target: $26 → $18
Current: $2.56
Upside: +603.13%
Reiterated: Buy
Price Target: $14
Current: $0.9361
Upside: +1,395.57%
Reiterated: Buy
Price Target: $8 → $16
Current: $2.03
Upside: +688.18%
Reiterated: Buy
Price Target: $13 → $42
Current: $9.67
Upside: +334.33%
Reiterated: Buy
Price Target: $154
Current: $75.14
Upside: +104.95%
Reiterated: Buy
Price Target: $28
Current: $6.91
Upside: +305.21%
Initiated Coverage: Buy
Price Target: $16
Current: $4.21
Upside: n/a
Reiterated: Buy
Price Target: $80 → $40
Current: $8.60
Upside: n/a
Initiated Coverage: Buy
Price Target: $5
Current: $0.5744
Upside: n/a
Reiterated: Buy
Price Target: $9 → $17
Current: $3.82
Upside: n/a
Reiterated: Buy
Price Target: $12 → $4
Current: $1.06
Upside: n/a
Initiated Coverage: Buy
Price Target: $36
Current: $49.55
Upside: n/a
Reiterated: Buy
Price Target: $28
Current: $1.33
Upside: n/a
Reiterated: Buy
Price Target: $10 → $8
Current: $0.3278
Upside: n/a
Reiterated: Buy
Price Target: $7
Current: $3.44
Upside: n/a
Reiterated: Buy
Price Target: $68
Current: $121.40
Upside: n/a
Initiated Coverage: Buy
Price Target: $6
Current: $0.3855
Upside: n/a
Rated: Buy
Price Target: $12 → $18
Current: $1.15
Upside: n/a
Initiated Coverage: Buy
Price Target: $7
Current: $1.59
Upside: n/a
Reiterated: Buy
Price Target: $8
Current: $0.000001
Upside: n/a
Rated: Buy
Price Target: $35
Current: $23.85
Upside: n/a
Reiterated: Buy
Price Target: $31 → $25
Current: $7.47
Upside: n/a
Downgraded: Hold
Price Target: $14 → $1.5
Current: $3.07
Upside: n/a
Reiterated: Buy
Price Target: $5 → $3
Current: $13.00
Upside: n/a
Rated: Buy
Price Target: $68
Current: $27.42
Upside: n/a
Initiated Coverage: Buy
Price Target: $6
Current: $142.85
Upside: n/a
Reiterated: Buy
Price Target: $23
Current: $0.9893
Upside: n/a